Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
<p>Water plot of best response in lung NEN.</p>
שמור ב:
| מחבר ראשי: | |
|---|---|
| מחברים אחרים: | , , , , , , , , , , , , , , , , , , , , |
| יצא לאור: |
2025
|
| נושאים: | |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
| _version_ | 1849927633331027968 |
|---|---|
| author | Dwight H. Owen (15034782) |
| author2 | Brooke Benner (15054338) Lai Wei (15023852) Vineeth Sukrithan (15054341) Ashima Goyal (15054344) Ye Zhou (15054347) Carly Pilcher (15054350) Sheryl-Ann Suffren (15054353) Gwen Christenson (15054356) Nancy Curtis (15054359) Megan Jukich (15054362) Emily Schwarz (15054365) Himanshu Savardekar (15054368) Ruthann Norman (15054371) Sarah Ferguson (15054374) Barbara Kleiber (15054377) Robert Wesolowski (8863505) William E. Carson (15054380) Gregory A. Otterson (15054383) Claire F. Verschraegen (15054386) Manisha H. Shah (15054389) Bhavana Konda (15054392) |
| author2_role | author author author author author author author author author author author author author author author author author author author author author |
| author_facet | Dwight H. Owen (15034782) Brooke Benner (15054338) Lai Wei (15023852) Vineeth Sukrithan (15054341) Ashima Goyal (15054344) Ye Zhou (15054347) Carly Pilcher (15054350) Sheryl-Ann Suffren (15054353) Gwen Christenson (15054356) Nancy Curtis (15054359) Megan Jukich (15054362) Emily Schwarz (15054365) Himanshu Savardekar (15054368) Ruthann Norman (15054371) Sarah Ferguson (15054374) Barbara Kleiber (15054377) Robert Wesolowski (8863505) William E. Carson (15054380) Gregory A. Otterson (15054383) Claire F. Verschraegen (15054386) Manisha H. Shah (15054389) Bhavana Konda (15054392) |
| author_role | author |
| dc.creator.none.fl_str_mv | Dwight H. Owen (15034782) Brooke Benner (15054338) Lai Wei (15023852) Vineeth Sukrithan (15054341) Ashima Goyal (15054344) Ye Zhou (15054347) Carly Pilcher (15054350) Sheryl-Ann Suffren (15054353) Gwen Christenson (15054356) Nancy Curtis (15054359) Megan Jukich (15054362) Emily Schwarz (15054365) Himanshu Savardekar (15054368) Ruthann Norman (15054371) Sarah Ferguson (15054374) Barbara Kleiber (15054377) Robert Wesolowski (8863505) William E. Carson (15054380) Gregory A. Otterson (15054383) Claire F. Verschraegen (15054386) Manisha H. Shah (15054389) Bhavana Konda (15054392) |
| dc.date.none.fl_str_mv | 2025-11-25T13:05:31Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30707306 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Supplementary_Figure_1_from_A_Phase_II_Clinical_Trial_of_Nivolumab_and_Temozolomide_for_Neuroendocrine_Neoplasms/30707306 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Therapeutic Research and Development Immuno-oncology Clinical Research and Trials Chemotherapy Combination chemotherapy Clinical Trial Results Phase II clinical trials Endocrine-Related Cancers Immunotherapy Checkpoint blockade Lung Cancer |
| dc.title.none.fl_str_mv | Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Water plot of best response in lung NEN.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_3b34f58c9ad381e30e91f7d3b604ea21 |
| identifier_str_mv | 10.1158/1078-0432.30707306 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30707306 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine NeoplasmsDwight H. Owen (15034782)Brooke Benner (15054338)Lai Wei (15023852)Vineeth Sukrithan (15054341)Ashima Goyal (15054344)Ye Zhou (15054347)Carly Pilcher (15054350)Sheryl-Ann Suffren (15054353)Gwen Christenson (15054356)Nancy Curtis (15054359)Megan Jukich (15054362)Emily Schwarz (15054365)Himanshu Savardekar (15054368)Ruthann Norman (15054371)Sarah Ferguson (15054374)Barbara Kleiber (15054377)Robert Wesolowski (8863505)William E. Carson (15054380)Gregory A. Otterson (15054383)Claire F. Verschraegen (15054386)Manisha H. Shah (15054389)Bhavana Konda (15054392)CancerTherapeutic Research and DevelopmentImmuno-oncologyClinical Research and TrialsChemotherapyCombination chemotherapyClinical Trial ResultsPhase II clinical trialsEndocrine-Related CancersImmunotherapyCheckpoint blockadeLung Cancer<p>Water plot of best response in lung NEN.</p>2025-11-25T13:05:31ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30707306https://figshare.com/articles/figure/Supplementary_Figure_1_from_A_Phase_II_Clinical_Trial_of_Nivolumab_and_Temozolomide_for_Neuroendocrine_Neoplasms/30707306CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307073062025-11-25T13:05:31Z |
| spellingShingle | Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms Dwight H. Owen (15034782) Cancer Therapeutic Research and Development Immuno-oncology Clinical Research and Trials Chemotherapy Combination chemotherapy Clinical Trial Results Phase II clinical trials Endocrine-Related Cancers Immunotherapy Checkpoint blockade Lung Cancer |
| status_str | publishedVersion |
| title | Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms |
| title_full | Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms |
| title_fullStr | Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms |
| title_full_unstemmed | Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms |
| title_short | Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms |
| title_sort | Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms |
| topic | Cancer Therapeutic Research and Development Immuno-oncology Clinical Research and Trials Chemotherapy Combination chemotherapy Clinical Trial Results Phase II clinical trials Endocrine-Related Cancers Immunotherapy Checkpoint blockade Lung Cancer |